Health Assembly Biosciences Presents New Data at AASLD The Liver Globe News Wire Nov 6, 2022 Data demonstrating nanomolar potency of core inhibitor ABI-4334 to disrupt the hepatitis B virus (HBV) life cycle at multiple points supports advancement into clinical studies First data presented on preclinical characterization of…